The diagnosis is typically clinicopathological, requiring the presence of nonnecrotizing granulomas on tissue biopsy, except in the case of three distinct clinical manifestations of sarcoidosis ...

Racial differences in the clinical manifestations and course of sarcoidosis are well documented; however, there is no specific association between mortality and ethnicity. [10] Black patients are ...

clinical signs or symptoms consistent with sarcoidosis; (3) no other obvious explanation for the granulomatous disease; and (4) age > 18 years. Subjects were characterized in a number of ways ...

Cardiac sarcoidosis and ACM genetic variants coexist with distinct features, highlighting the need for refined clinical ...

Several uncontrolled and controlled studies, as well as common clinical experience, have amply confirmed the suppressive effect of steroids.5-11 In pulmonary sarcoidosis the most ... later reduction ...

The FSR Pilot Grant program, initiated in 2018, seeks to fund innovative research in both clinical and basic science settings ...

CFO updates stated that Roivant ended the quarter with $5.2 billion in cash and marketable securities, including $500 million authorized for additional share buybacks and $1 billion in stock ...

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

People with metastatic cancer who regularly report their symptoms via a home-based electronic monitoring system experienced ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

Sarcoidosis is a rare inflammatory condition that develops when groups of cells in your immune system form patches of swollen ...